ALACHUA, Fla., Dec. 15 /PRNewswire-FirstCall/ -- Tutogen Medical, Inc. , a leading manufacturer of sterile biological implant products made from human (allograft) and animal (xenograft) tissue, will report on Thursday, December 21, 2006 financial results for the fourth quarter and fiscal-year 2006 ended September 30, 2006. The Company will discuss these results in a conference call scheduled for 10:00 a.m. ET, December 21, 2006.
Interested parties can access the call by dialing (888) 408-9532 or (706) 679-5064 or by accessing the web cast at http://www.tutogen.com/investor.asp. A replay of the call will be available at (800) 642-1687 or (706) 645-9291, conference ID number: 4348290 for 3 days following the call, and the web cast can be accessed at http://www.tutogen.com/investor.asp for 30 days.
About Tutogen Medical, Inc.
Tutogen Medical, Inc. manufactures sterile biological implant products made from human (allograft) and animal (xenograft) tissue. Tutogen utilizes its Tutoplast Process(R) of tissue preservation and viral inactivation to manufacture and deliver sterile bio-implants used in spinal/trauma, urology, dental, ophthalmology, and general surgery procedures. The Company's Tutoplast(R) products are sold and distributed worldwide by Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer Holdings, Inc., Davol Inc. subsidiary of C.R. Bard Inc., the Mentor Corporation (Mentor), Coloplast Corp., IOP, Inc. and through independent distributors internationally. For more information, visit the Company's Web site at http://www.tutogen.com.
Tutogen Medical, Inc.CONTACT: L. Robert Johnston, Jr., Chief Financial Officer of TutogenMedical, Inc., +1-386-462-0402, bjohnston@tutogen.com; or Joe Diaz, JoeDorame or Robert Blum, all of Lytham Partners, LLC, +1-602-889-9700, forTutogen Medical, Inc.
